Literature DB >> 21247901

Histone deacetylases 9 and 10 are required for homologous recombination.

Shweta Kotian1, Sandhya Liyanarachchi2, Arthur Zelent3, Jeffrey D Parvin4.   

Abstract

We tested the role of histone deacetylases (HDACs) in the homologous recombination process. A tissue-culture based homology-directed repair assay was used in which repair of a double-stranded break by homologous recombination results in gene conversion of an inactive GFP allele to an active GFP gene. Our rationale was that hyperacetylation caused by HDAC inhibitor treatment would increase chromatin accessibility to repair factors, thereby increasing homologous recombination. Contrary to expectation, treatment of cells with the inhibitors significantly reduced homologous recombination activity. Using RNA interference to deplete each HDAC, we found that depletion of either HDAC9 or HDAC10 specifically inhibited homologous recombination. By assaying for sensitivity of cells to the interstrand cross-linker mitomycin C, we found that treatment of cells with HDAC inhibitors or depletion of HDAC9 or HDAC10 resulted in increased sensitivity to mitomycin C. Our data reveal an unanticipated function of HDAC9 and HDAC10 in the homologous recombination process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247901      PMCID: PMC3048658          DOI: 10.1074/jbc.C110.194233

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

Authors:  A J Pierce; R D Johnson; L H Thompson; M Jasin
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

2.  Hdac3 is essential for the maintenance of chromatin structure and genome stability.

Authors:  Srividya Bhaskara; Sarah K Knutson; Guochun Jiang; Mahesh B Chandrasekharan; Andrew J Wilson; Siyuan Zheng; Ashwini Yenamandra; Kimberly Locke; Jia-Ling Yuan; Alyssa R Bonine-Summers; Christina E Wells; Jonathan F Kaiser; M Kay Washington; Zhongming Zhao; Florence F Wagner; Zu-Wen Sun; Fen Xia; Edward B Holson; Dineo Khabele; Scott W Hiebert
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

3.  Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo.

Authors:  D Kadosh; K Struhl
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

4.  Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes.

Authors:  K Ikeda; D J Steger; A Eberharter; J L Workman
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.

Authors:  Koji Nakanishi; Yun-Gui Yang; Andrew J Pierce; Toshiyasu Taniguchi; Martin Digweed; Alan D D'Andrea; Zhao-Qi Wang; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-13       Impact factor: 11.205

6.  Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.

Authors:  J W Han; S H Ahn; S H Park; S Y Wang; G U Bae; D W Seo; H K Kwon; S Hong; H Y Lee; Y W Lee; H W Lee
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

7.  Role of SIRT1 in homologous recombination.

Authors:  Miriam Uhl; Andreea Csernok; Sevtap Aydin; Rolf Kreienberg; Lisa Wiesmüller; Susanne Andrea Gatz
Journal:  DNA Repair (Amst)       Date:  2010-01-25

8.  Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

Authors:  Derek J R Ransburgh; Natsuko Chiba; Chikashi Ishioka; Amanda Ewart Toland; Jeffrey D Parvin
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

9.  Histone deacetylase 10 relieves repression on the melanogenic program by maintaining the deacetylation status of repressors.

Authors:  I-Lu Lai; Tung-Ping Lin; Ya-Li Yao; Ching-Yi Lin; Mei-Ju Hsieh; Wen-Ming Yang
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

10.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining.

Authors:  Kyle M Miller; Jorrit V Tjeertes; Julia Coates; Gaëlle Legube; Sophie E Polo; Sébastien Britton; Stephen P Jackson
Journal:  Nat Struct Mol Biol       Date:  2010-08-29       Impact factor: 15.369

View more
  37 in total

1.  Variants in an Hdac9 intronic enhancer plasmid impact Twist1 expression in vitro.

Authors:  Tyler E Siekmann; Madelyn M Gerber; Amanda Ewart Toland
Journal:  Mamm Genome       Date:  2015-12-31       Impact factor: 2.957

2.  HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma.

Authors:  Xiangxiang Tao; Yifeng Yan; Linming Lu; Bing Chen
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

3.  Elucidation of IgH 3' region regulatory role during class switch recombination via germline deletion.

Authors:  Alexis Saintamand; Pauline Rouaud; Faten Saad; Géraldine Rios; Michel Cogné; Yves Denizot
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

4.  Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.

Authors:  Wenxing Fan; Jie Huang; Hua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  HDAC10 as a potential therapeutic target in ovarian cancer.

Authors:  Muhtadi M Islam; Tapahsama Banerjee; Colin Z Packard; Shweta Kotian; Karuppaiyah Selvendiran; David E Cohn; Jeffrey D Parvin
Journal:  Gynecol Oncol       Date:  2017-01-07       Impact factor: 5.482

6.  NUSAP1 influences the DNA damage response by controlling BRCA1 protein levels.

Authors:  Shweta Kotian; Tapahsama Banerjee; Ainsley Lockhart; Kun Huang; Umit V Catalyurek; Jeffrey D Parvin
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

Review 7.  Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.

Authors:  Prithviraj Bose; Yun Dai; Steven Grant
Journal:  Pharmacol Ther       Date:  2014-04-24       Impact factor: 12.310

Review 8.  HDAC inhibitor-based therapies: can we interpret the code?

Authors:  Maria New; Heidi Olzscha; Nicholas B La Thangue
Journal:  Mol Oncol       Date:  2012-10-23       Impact factor: 6.603

Review 9.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

10.  Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2.

Authors:  Rangasudhagar Radhakrishnan; Yixuan Li; Shengyan Xiang; Fenghua Yuan; Zhigang Yuan; Elphine Telles; Jia Fang; Domenico Coppola; David Shibata; William S Lane; Yanbin Zhang; Xiaohong Zhang; Edward Seto
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.